CY2462B1 - Cyclohexyl dihydrobenzofuranes. - Google Patents

Cyclohexyl dihydrobenzofuranes.

Info

Publication number
CY2462B1
CY2462B1 CY0400051A CY0400051A CY2462B1 CY 2462 B1 CY2462 B1 CY 2462B1 CY 0400051 A CY0400051 A CY 0400051A CY 0400051 A CY0400051 A CY 0400051A CY 2462 B1 CY2462 B1 CY 2462B1
Authority
CY
Cyprus
Prior art keywords
pct
date nov
sec
dihydrobenzofuranes
cyclohexyl
Prior art date
Application number
CY0400051A
Other languages
English (en)
Inventor
Hermann Amschler
Thomas Baer
Dieter Flockerzi
Beate Gutterer
Ulrich Thibaut
Armin Hatzelmann
Hildegard Boss
Dietrich Haefner
Hans-Peter Kley
Rolf Beume
Wolf-Ruediger Ulrich
Thomas Martin
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CY2462B1 publication Critical patent/CY2462B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Lubricants (AREA)
  • Liquid Carbonaceous Fuels (AREA)
CY0400051A 1995-05-18 2004-06-23 Cyclohexyl dihydrobenzofuranes. CY2462B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH147195 1995-05-18
DE19601911 1996-01-22

Publications (1)

Publication Number Publication Date
CY2462B1 true CY2462B1 (en) 2005-06-03

Family

ID=25687750

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0400051A CY2462B1 (en) 1995-05-18 2004-06-23 Cyclohexyl dihydrobenzofuranes.

Country Status (11)

Country Link
US (1) US6080782A (es)
EP (1) EP0828727B1 (es)
JP (1) JPH11505539A (es)
AT (1) ATE230404T1 (es)
AU (1) AU705723B2 (es)
CA (1) CA2221351A1 (es)
CY (1) CY2462B1 (es)
DE (1) DE59610031D1 (es)
DK (1) DK0828727T3 (es)
ES (1) ES2189871T3 (es)
WO (1) WO1996036626A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2258728C (en) 1996-06-19 2011-09-27 Rhone Poulenc Rorer Limited Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
AU5320698A (en) * 1996-11-20 1998-06-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted dihydrobenzofurans as pde inhibitors
IL140468A0 (en) * 1998-07-06 2002-02-10 Byk Gulden Lomberg Chem Fab Benzoxazole derivatives and pharmaceutical compositions containing the same
GB9828340D0 (en) * 1998-12-22 1999-02-17 Novartis Ag Organic compounds
BRPI0013478B8 (pt) 1999-08-21 2016-12-27 Altana Pharma Ag medicamento compreendendo inibidor pde e uso de roflumilast
EP1316316B1 (en) * 2000-09-06 2012-04-04 Mitsubishi Tanabe Pharma Corporation Preparations for oral administration
EP1199074A1 (en) * 2000-09-15 2002-04-24 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production
EP1188438A1 (en) * 2000-09-15 2002-03-20 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production
AU2002230217B2 (en) * 2001-02-15 2005-02-17 Tanabe Seiyaku Co., Ltd. Tablets quickly disintegrated in oral cavity
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249435A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 HT receptor mediated neurogenesis
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
KR20090064418A (ko) 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225869B1 (en) * 1992-04-02 2007-11-28 Smithkline Beecham Corp Compounds with antiallergic and antiinflammatory activity and pharmaceutical compns. contg. them
EP0634930A4 (en) * 1992-04-02 1995-02-22 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases.
AU3924993A (en) * 1992-04-02 1993-11-08 Smithkline Beecham Corporation Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
AU4717693A (en) * 1992-07-28 1994-02-14 Rhone-Poulenc Rorer Limited Inhibitors of c-amp phosphodiesterase and tnf
CN1163493C (zh) * 1995-05-19 2004-08-25 协和发酵工业株式会社 含氧杂环化合物

Also Published As

Publication number Publication date
US6080782A (en) 2000-06-27
AU5764496A (en) 1996-11-29
EP0828727B1 (de) 2003-01-02
JPH11505539A (ja) 1999-05-21
DE59610031D1 (de) 2003-02-06
ES2189871T3 (es) 2003-07-16
EP0828727A1 (de) 1998-03-18
WO1996036626A1 (de) 1996-11-21
DK0828727T3 (da) 2003-04-22
AU705723B2 (en) 1999-05-27
ATE230404T1 (de) 2003-01-15
CA2221351A1 (en) 1996-11-21

Similar Documents

Publication Publication Date Title
AU5895496A (en) Phenyldihydrobenzofurans
CY2462B1 (en) Cyclohexyl dihydrobenzofuranes.
MXPA04012965A (es) Inhibidores virales.
MY132106A (en) New pyridazin-3(2h)-one derivatives
TNSN03144A1 (en) Pyrrolopyrimidines as protein kinase inhibitors
WO2003000343A3 (en) Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
AU2003297048A8 (en) Cyclohexyl compounds as ccr5 antagonists
MXPA05002871A (es) Derivados de benzodiazaepina y composiciones farmaceuticas que los contienen.
MY140872A (en) 5,7-diaminopyrazolo[4,3-d]pyrimidines with pde-5 inhibitory activity, compositions containing such derivatives and the use of such derivatives in the treatment of hypertension and other disorders
NO20052739L (no) CCR5-antagonister som medikamenter
BG103969A (en) C-4"-substituted macrolide derivatives
RS101304A (sr) Indolni, azaindolni i srodni heterociklični 4-alkenil piperidinski amidi
AP2003002929A0 (en) Pyrrolopyrimidines as protein kinase inhibitors
EA200000355A2 (ru) Промышленные изделия
AU2003300911A1 (en) Heterocyclic compounds as ccr5 antagonists
MXPA04010307A (es) Derivados 5-oxo y 5-tio de 5h-indeno`1,2-bipiridina con enlace al receptor a2a de la adenosina y actividad inhibidora de la fosfodiesterasa para el tratamiento de trastornos neurodegenerativos y enfermedades relacionadas con la inflamacion.
WO2001080860A3 (en) Daily treatment for erectile dysfunction using a pde5 inhibitor
TW200505448A (en) 5-hydroxyindoles with n-oxide groups and the use thereof as therapeutic agents
TW200505916A (en) 7-azaindoles and the use thereof as therapeutic agents
TW200503693A (en) 4-, 6- or 7-hydroxyindoles with n-oxide groups and the use thereof as therapeutic agents
CA2239053A1 (en) Diphenyl pyridyl ethane derivatives as pde iv inhibitors
MXPA02001308A (es) Derivados de pirido (1, 2-a)bencimidazol sustituidos en el anillo c-6 utiles en el tratamiento de trastornos del sistema nervioso central.
GEP20094596B (en) Compositions comprising phosphodiesterase inhibitors for the treatment of sexual dysfunction
KR100408626B1 (en) Pharmaceutical composition for inhibiting the activity of phosphodiesterase